584
Participants
Start Date
September 9, 2019
Primary Completion Date
September 27, 2021
Study Completion Date
September 27, 2021
Experimental: Rosuvastatin/Ezetimibe 10
"* Rosuvastatin/Ezetimibe 10/10mg~* orally administered once daily for 90 days"
Active Comparator: Rosuvastatin 20mg
"* Rosuvastatin 20mg~* orally administered once daily for 90 days"
Korea University Ansan Hospital, Ansan-si
Hallym University Medical Center, Anyang-si
Myongji Hospital, Goyang-si
Inje University Ilsan Paik Hospital, Ilsan
Chung-Ang University Hopital, Seoul
Ewha Womans University Seoul hospital, Seoul
Korea University Guro Hospital, Seoul
Kyung-Hee University Medical Center, Seoul
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul
Seoul National University Hospital, Seoul
Seoul St Mary's Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Ewha Womans University Seoul Hospital
OTHER
Severance Hospital
OTHER
Korea University Ansan Hospital
OTHER
Korea University Guro Hospital
OTHER
Myongji Hospital
OTHER
Seoul St. Mary's Hospital
OTHER
Samsung Medical Center
OTHER
Seoul National University Hospital
OTHER
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
OTHER
Hallym University Medical Center
OTHER
Kyunghee University Medical Center
OTHER
Inje University Ilsan Paik Hospital
OTHER
Keun-Sik Hong
OTHER